Compliance & Accreditation · July 29, 2026 · Updated July 30, 2026
Blood Bank Record Retention: What to Keep and for How Long
Schedule F Part XIIB requires a blood centre to keep its records for five years.1 What it does not do is say what the five years runs from. The licence condition that does name a date ties the testing records to the date of manufacture,2 while the widely repeated “two years from the date of the last entry” belongs to licences to sell drugs and not to a blood centre.3 Five years is the floor, the starting date depends on which record you are holding, and your policy should say which basis it uses.
Retention and completeness are also different questions. Scanning a register preserves what somebody wrote on the page; it cannot create the donor, testing, component or issue entries that were never made. Both will be tested, and the second one usually fails first.
What Part XIIB requires you to keep
Part XIIB names the records by their particulars rather than by a form number, and a single note at the end of the list sets one period for all of them.1 If your retention schedule is organised around form numbers, check it against this list instead, because the Drugs and Cosmetics Rules, 1945 do not issue a prescribed record form for blood centre transactions.
| Record Part XIIB names | Particulars it specifies |
|---|---|
| Blood donor record | Serial number, date of bleeding, donor name, address and signature, age, weight, haemoglobin, blood grouping, blood pressure, medical examination, bag number, the patient’s details where the donation is a replacement, whether the donation is voluntary or replacement, deferral records, and the signature of the medical officer in charge |
| Master record for blood and its components | Bag serial number, date of collection, date of expiry, quantity in millilitres, ABO and Rh group, results for HIV 1 and HIV 2 antibodies, malaria, VDRL, hepatitis B surface antigen and hepatitis C virus antibody, irregular antibodies where present, donor name and address, utilisation issue number, components prepared or discarded, and the signature of the medical officer in charge |
| Issue register | Serial number, date and time of issue, bag serial number, ABO and Rh group, total quantity in millilitres, recipient name and address, recipient group, unit or institution, cross-matching report details, and the indication for transfusion |
| Records of components supplied | Quantity supplied, compatibility report, recipient details, and the signature of the issuing person |
| Records of anticoagulant bags | For ACD, CPD, CPD-A and SAGM bags: manufacturer, batch number, date of supply, and testing results |
| Register of diagnostic kits and reagents used | Name of the kit or reagent, batch number, date of expiry, and date of use |
| Cross-matching report | The report the centre must issue to the patient together with the blood unit |
| Transfusion adverse reaction records | The reactions reported back to the centre |
| Purchase, use and stock records | Disposable needles, syringes and blood bags: what was bought, what was used, and what is in hand |
Read the list as one trail rather than nine filing cabinets. The bag serial number appears in the donor record, the master record and the issue register, which is what makes donor-to-recipient traceability testable at all. Keep the worksheets, compatibility records and corrections that substantiate an entry with the record they belong to, for the same period. A register retained without them proves that something was written, not that it was right.
What the five years runs from
Three different answers apply, and knowing which one you are relying on is the whole of the problem.
For the records in the list above, Part XIIB sets five years and names no starting date.1 For the testing records and registers, the licence condition under Rule 122G is specific: they are to be maintained for five years from the date of manufacture.2 For a bound register that stays open for years, neither answer is much practical use on its own, and the conservative course is to hold the register until five years after its final entry.
That last one is prudence, not the wording of a rule, and it is worth being precise about the difference in your own documents. State the basis in your retention policy, apply it consistently, and do not present a cautious internal practice to an assessor as a statutory requirement. Where a licence condition or a state authority sets a longer period, the longer period governs.
Why the two-year rule does not apply to your centre
The phrase that causes most of the confusion is real. Rule 65(7) provides that, except where otherwise provided in the Rules, registers and records are to be preserved for not less than two years from the date of the last entry.3 Rule 65 sets the conditions of licences to sell, stock or distribute drugs, and its own words defer to any provision made elsewhere.
A blood centre is provided for elsewhere. Part XIIB and the Rule 122G licence conditions both set five years, so the two-year period never reaches your donor records, and the “last entry” trigger it carries does not travel with it. This matters practically in hospitals, where a pharmacy retention procedure written from Rule 65 sometimes becomes the template for the blood centre. Two years and a last-entry calculation are correct for the pharmacy counter and wrong by three years for the blood centre next door. It belongs in the same category of avoidable finding as the rest of your Drugs and Cosmetics Rules compliance checklist.
Why a scanned register may still be incomplete
A scan preserves the content visible on the page. Omitted fields stay omitted, missing attachments stay missing, and two separate registers still need a common identifier before anyone can show that their entries concern the same unit.
Before you treat a scanned archive as complete, pick one unit and check that the archive can produce:
- the donor and collection entry;
- the matching bag serial number;
- the grouping and test entries, with the kit and batch behind them;
- component preparation records, where components were made;
- the issue entry or the documented final disposition; and
- the history of any correction made to those records.
If one of those links exists only in a live spreadsheet or on paper outside the archive, what you have is a partial record trail with a complete-looking index. Poorly controlled software leaves the same gap by a different route, which the comparison of manual and digital blood bank management sets out.
A retention control that survives an inspection
Keep a retention index that records, for each record set, its name, the date range it covers, where it is stored, the date of its final entry, the earliest date it may be destroyed, and who authorised any destruction. Keep the index separate from the records themselves. Its purpose is to make an absence visible: without it, a missing box or an unrestored database export looks exactly like a record nobody has asked for yet.
Then test it the way an assessor will, by unit identifier rather than by register name. Ask someone other than the person who filed it to retrieve one unit end to end. Generate returns from these source records instead of maintaining a separate set of totals, which is also what keeps blood bank reporting defensible. Whether the centre runs on paper or on a blood bank management system, the licensee remains responsible for records that are complete, legible and available for the whole five years.
Sources
- Drugs and Cosmetics Rules, 1945, Schedule F, Part XIIB, section L (Records) and its retention note cdsco.gov.in
- Drugs and Cosmetics Rules, 1945, Rule 122G, conditions of licence, clause (i)(c) cdsco.gov.in
- Drugs and Cosmetics Rules, 1945, Rule 65(7), conditions of licences to sell drugs cdsco.gov.in